The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVersarien Regulatory News (VRS)

Share Price Information for Versarien (VRS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.105
Bid: 0.10
Ask: 0.105
Change: -0.002 (-1.91%)
Spread: 0.005 (5.00%)
Open: 0.1005
High: 0.105
Low: 0.1005
Prev. Close: 0.1045
VRS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition and Trading Update

19 Jan 2017 13:21

RNS Number : 6373U
Versarien PLC
19 January 2017
 

 

 

19 January 2017

 

Versarien plc

 

 

Acquisition of Cambridge Graphene Limited

and Trading Update

 

Versarien plc (AIM:VRS) ("Versarien" or the "Company" or the "Group"), the advanced materials group, is pleased to announce that it that it has acquired 85 per cent. of the issued share capital of Cambridge Graphene Limited ("Cambridge Graphene") (the "Acquisition") and to provide an update on current trading.

Acquisition of Cambridge Graphene

Cambridge Graphene, currently owned by its management and Cambridge Enterprise Ltd. (the commercialization arm of the University of Cambridge), supplies novel inks based on graphene and related materials, using patented processes and develops graphene materials technology for licensing to manufacturers.

The Directors believe the Acquisition presents an exciting opportunity for Versarien to acquire a business with complementary skills and operations to the Company's current graphene activities, particularly with Cambridge Graphene's existing expertise and opportunities in the graphene ink area.

Like the Company's existing subsidiary, 2-DTech, born out of the University of Manchester, Cambridge Graphene was born out of the University of Cambridge to commercialise the university's graphene expertise. The Universities of Manchester and Cambridge are the two centres of excellence for graphene in the UK. Following the acquisition of Cambridge Graphene, both universities will be shareholders in the Company, positioning Versarien at the epicenter of the commercial development of graphene both in the UK and globally.

Versarien believes that the addition of Cambridge Graphene to its portfolio significantly increases the Company's ability to advance its experience and expertise to commercialise the considerable market opportunities for graphene both in the UK and internationally. Material produced at both Manchester and Cambridge will be able to be used at either site in product development and for supply to customers.

The total consideration for the Acquisition is £170,000 to be settled by £25,000 in cash, from the Company's existing resources, and the issue of 1,450,000 new ordinary shares in the Company at an agreed price of 10p per share ("New Ordinary Shares"). For the year ended 31 May 2016 Cambridge Graphene had negative net assets of £9,047 and made a profit before tax of £2,809. The vendors will retain the 15% shareholding in Cambridge Graphene not being acquired by Versarien.

Trading Update

The current financial year to 31 March 2017 has been one of significant investment and development for the Company with a number of notable events.

AAC Cyroma, acquired on 3 October 2016, has been successfully integrated into the Group and its performance has been slightly ahead of expectations. With the acquisition of Cambridge Graphene announced today and the significant number of commercial collaborations announced by the Company during the current financial year to develop graphene related products in areas including healthcare, 3D printing, batteries, PAEK plastics and carbon fibre composite structures, the Board believes that the Group is very well positioned at the forefront of the development and commercialisation of graphene.

On 29 November 2016 the Group announced a significant graphene order for a carbon fibre composite related application, which the Company believes is one of the first significant orders placed in the UK for the supply of high quality graphene. The Board is pleased to report that the order was successfully completed and delivered ahead of schedule, despite the requirement for the tripling of manufacturing capacity to fulfill the order, demonstrating the ability to scale up at short notice.

The Group continues to make investments in its graphene related activities, including the ordering of additional capital equipment, to take advantage of the global opportunities it is seeing and expects further orders in the coming months.

As outlined in the Company's interim results announced on 29 November 2016, the Company's Hard Wear products business, Total Carbide, has been relocated to a new facility on the Westcott Venture Park in Oxfordshire. This necessary move, whilst being disruptive, has provided the Group with ample modern manufacturing capacity for both its Hard Wear and Thermal products which require similar engineering equipment. Trading conditions remain challenging in the Company's Hard Wear products business serving the oil and gas sector, where order levels have continued to be depressed. However, there are signs of a gradual pick up with incoming orders showing improvement.

The Company's Thermal Products business, Versarien Technologies, has been restructured over recent months including the appointment of a new sales team. The translation of expressions of interest from potential customers into firm sales orders has been slower than previously anticipated, although Thermal Products continues to enjoy a substantial pipeline of enquiries.

The backdrop of difficult trading conditions in the Company's most significant revenue contributing business, Total Carbide, coupled with the continued investment in the Group's graphene related activities means the financial outcome for the Company's financial year ending 31 March 2017 is likely to see revenues slightly below current market forecasts with a larger than previously anticipated loss.

 

Neill Ricketts, CEO of Versarien, commented: "We are delighted with the acquisition of Cambridge Graphene and the opportunities it brings us. This addition to our existing graphene operations and in particular, 2-DTech, which we acquired from Manchester University in April 2014, bridges the gap between the two centres of excellence for graphene and between them really puts us at the centre of the graphene universe.

"We are also very pleased to welcome a new team and shareholders, new IP and an existing partnership agreement with the Cambridge Graphene Centre and The University of Cambridge.

Whilst trading conditions remain challenging in our mature Hard Wear products business, we continue to invest in developing our graphene capabilities to take advantage of this enormous global opportunity and look forward to the future with confidence."

Issue of New Ordinary Shares Pursuant to the Acquisition

Application for admission to trading on AIM of the 1,450,000 New Ordinary Shares being issued pursuant to the Acquisition will be made and admission is expected to take place on or around 26 January 2017. The New Ordinary Shares will rank pari passu with the existing Ordinary Shares in issue.

 In accordance with the provisions of the Disclosure Guidance and Transparency Rules of the FCA, the Company confirms that, following the Acquisition, its issued share capital will comprise 121,294,003 Ordinary Shares of 1 pence each. All Ordinary Shares shall have equal voting rights and none of the Ordinary Shares are held in treasury. The total number of voting rights in the Company immediately following Admission will therefore be 121,294,003.

 

This announcement includes inside information as defined in Article 7 of the Market Abuse Regulation No. 596/2014 and is disclosed in accordance with the Company's obligations under Article 17 of those Regulations.

 

 

For further information please contact:

 

Versarien plc

www.versarien.com

Neill Ricketts - Chief Executive Officer

+44 (0) 1242 269 122

Chris Leigh - Chief Financial Officer

WH Ireland (Nominated Adviser)

www.whirelandplc.com

Mike Coe / Ed Allsopp

+44 (0) 117 945 3470

IFC Advisory (Financial PR and IR)

www.investor-focus.co.uk

Tim Metcalfe / Graham Herring / Heather Armstrong /

Miles Nolan

+44 (0) 20 3053 8671

 

 

Notes to Editors:

 

About Versarien

 

Versarien plc (AIM:VRS), is an advanced engineering materials group. Leveraging proprietary technology, the Group creates innovative engineering solutions for its clients in a diverse range of industries. Versarien has four subsidiaries operating under two divisions:

 

Thermal and Hard Wear Products

Versarien Technologies Ltd. which owns the exclusive rights to a patent-protected additive process for creating advanced micro-porous metals targeting the thermal management industry and manufactures extruded aluminium heat sinks for the electronics and computing industries. www.versarien-technologies.co.uk 

Total Carbide Ltd, a leading manufacturer in sintered tungsten carbide for applications in arduous environments such as the oil and gas industry. www.totalcarbide.com 

 

Graphene and Plastics

2-DTech Ltd, which specialises in the supply, characterisation and early stage development of graphene products. www.2-dtech.com

ACC Cyroma Ltd, which specialises in the supply of vacuum-formed and injection-moulded products to the automotive, construction, utilities and retail industry sectors. Using Versarien's existing graphene manufacturing capabilities, AAC will have the ability to produce graphene-enhanced plastic products. www.aaccyroma.co.uk

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCSFSFDUFWSEEF
Date   Source Headline
30th Apr 202411:59 amRNSResult of AGM
28th Mar 20247:00 amRNSAudited Results for year ended 30 September 2023
28th Mar 20247:00 amRNSTotal Voting Rights
20th Mar 20248:33 amRNSPlacing to raise £615,000
14th Mar 20247:00 amRNSSouth American Graphinks Agreements
11th Mar 20247:00 amRNSSale of Korean Assets and Licencing of IP
16th Feb 20242:22 pmRNSNotification of final results
7th Feb 20247:00 amRNSReceipt of Legal Claims
31st Jan 20247:00 amRNSTotal Voting Rights
23rd Jan 20244:53 pmRNSHolding(s) in Company
23rd Jan 20241:24 pmRNSHolding(s) in Company
19th Jan 20247:00 amRNSPlacing to raise £400,000
10th Jan 202411:29 amRNSResult of General Meeting
20th Dec 20237:00 amRNSCompany Update and Notice of General Meeting
30th Nov 20237:00 amRNSTotal Voting Rights
8th Nov 20237:00 amRNSPlacing to raise £454,822
30th Oct 202311:52 amRNSResult of General Meeting
30th Oct 20237:00 amRNSGeneral Meeting Statement
12th Oct 20237:00 amRNSNotice of General Meeting
2nd Oct 20237:00 amRNSCorporate Update
13th Sep 20237:00 amRNSTurnaround Strategy - Gnanomat Grant Award
31st Jul 20237:00 amRNSTotal Voting Rights
18th Jul 20234:31 pmRNSDirectorate Changes
14th Jul 20237:00 amRNSPlacing to raise £650,000
4th Jul 202310:54 amRNSResult of General Meeting
4th Jul 20237:00 amRNSGeneral Meeting Statement
15th Jun 20237:00 amRNSNotice of General Meeting
9th Jun 20237:00 amRNSInterim Results
31st May 20237:00 amRNSTotal Voting Rights
17th May 20237:00 amRNSSuccessful Cementene precast concrete trials
3rd May 20239:30 amRNSPlacing and Update on Turnaround Strategy
31st Mar 20237:00 amRNSTotal Voting Rights
29th Mar 202311:22 amRNSResult of AGM
29th Mar 20237:00 amRNSAGM Statement
15th Mar 20237:00 amRNSPlacing to raise £318,000
14th Mar 20232:56 pmRNSFurther re Resignation of Chief Executive Officer
10th Mar 20237:00 amRNSResignation of Chief Executive Officer
6th Mar 20237:00 amRNSCostain Civil Engineering Project
1st Mar 202312:00 pmRNSUmbro Launch
28th Feb 20237:00 amRNSNotice of AGM and Posting of Annual Report
21st Feb 20237:00 amRNSResults for the 18 months ended 30 September 2022
9th Feb 20238:33 amRNSAIM Rule 17 Update
27th Jan 20237:00 amRNSGraphene-Wear OEKO-TEX Eco Passport certification
24th Jan 20231:56 pmRNSFinal Results Update
30th Dec 20227:00 amRNSTotal Voting Rights
6th Dec 20229:40 amRNSPlacing to raise £1.85 million
5th Dec 20224:40 pmRNSSecond Price Monitoring Extn
5th Dec 20224:35 pmRNSPrice Monitoring Extension
5th Dec 20227:00 amRNSG-SCALE Update & Innovate UK Loan Variation
2nd Dec 20224:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.